|
|
|
|
Report of a recurrent mutation in ARS (component B) gene with severe Mal de Meleda in a large consanguineous Pakistani family
|
|
|
|
|
|
|
|
نویسنده
|
Nawaz Sadia ,Tariq Muhammad ,Azhar Aysha ,Rasool Mahmood ,Bakhtiar Marriam ,Ahmad Ilyas ,Shoaib ur Rehman ,Jameel Muhammad ,Khan Tahir Naeem ,Baig Shehla Anjum ,Klar Joakim ,Dahl Niklas ,Baig Shahid Mahmood
|
|
منبع
|
pakistan journal of medical sciences - 2011 - دوره : 27 - شماره : 3 - صفحه:686 -689
|
|
چکیده
|
Objective: to characterize the disease causing mutation in a large consanguineous pakistani family with severe mal de meleda (mdm) or keratosis palmoplantaris transgrediens, a rare autosomal recessive skin disorder. methodology: single nucleotide polymorphism (snps) genotyping was performed using the genechip mapping 250k array (affymetrix). homozygosity mapping and sorting of genomic regions were performed with dedicated software called autosnpa. selected regions were further investigated by genotyping with microsatellite markers derived from known and novel polymorphic repeats. two-point lod score calculation was performed by using the mlink of fastlink computer package. all three coding exons of ars (component b) gene were amplified by pcr and sequenced. conclusion: sequencing of all the coding exons of ars (component b) gene in the affected individuals revealed a recurrent missense mutation in exon 3 at base pair 256 from guanine to alanine (256g>a) and as a result the amino acid glycine is replaced by arginine at position 86 (g86r). this finding will facilitate control of affected mdm births in the pakistani families.
|
|
کلیدواژه
|
Mal de Meleda (MDM) ,Palmoplantar keratoderma (PPK) ,ARS (component B) gene.
|
|
آدرس
|
National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory,Health Biotechnology Division, Pakistan, National Institute for Biotechnology andGenetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and.Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory, Health Biotechnology Division, Pakistan, Pakistan Institute of Medical Sciences (PIMS), Children’s Hospital, Mother Child Health Center (MCHC), Pakistan, Uppsala University, Rudbeck Laboratory, Department of Genetics and Pathology, Sweden, Uppsala University, Rudbeck Laboratory, Department of Genetics and Pathology, Sweden, National Institute for Biotechnology and Genetic Engineering (NIBGE), Human Molecular Genetics Laboratory,Health Biotechnology Division, Pakistan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
Shoaib ur Rehman
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|